Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-02

FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Solco Healthcare US, LLC.)

View source ↗

Summary

The FDA approved the original application for olmesartan medoxomil from Solco Healthcare US, LLC., granting a generic option for treating hypertension. This app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)